Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 2
2009 5
2010 1
2011 6
2012 4
2013 4
2014 2
2015 6
2016 5
2017 3
2018 1
2019 1
2021 2
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR. Cipriani A, et al. Lancet. 2018 Apr 7;391(10128):1357-1366. doi: 10.1016/S0140-6736(17)32802-7. Epub 2018 Feb 21. Lancet. 2018. PMID: 29477251 Free PMC article. Review.
We excluded quasi-randomised trials and trials that were incomplete or included 20% or more of participants with bipolar disorder, psychotic depression, or treatment-resistant depression; or patients with a serious concomitant medical illness. ...In terms of efficacy, all …
We excluded quasi-randomised trials and trials that were incomplete or included 20% or more of participants with bipolar disorder, ps …
Agomelatine in depression.
Smeraldi E, Delmonte D. Smeraldi E, et al. Expert Opin Drug Saf. 2013 Nov;12(6):873-80. doi: 10.1517/14740338.2013.828690. Epub 2013 Sep 16. Expert Opin Drug Saf. 2013. PMID: 24033095 Review.
It may be a valuable pharmacological alternative in the clinical approach on depression. AREAS COVERED: The literature about agomelatine has been comprehensively reviewed. Agomelatine's efficacy, safety and tolerability are reviewed based on the studies under …
It may be a valuable pharmacological alternative in the clinical approach on depression. AREAS COVERED: The literature about agomelatine
Focus on agomelatine.
Green B. Green B. Curr Med Res Opin. 2011 Apr;27(4):745-9. doi: 10.1185/03007995.2011.554534. Epub 2011 Jan 27. Curr Med Res Opin. 2011. PMID: 21271795 Review.
SCOPE: This is a review of current evidence for clinical efficacy and safety, drawn from a literature review using Medline and PsycInfo in 2010 using search terms including agomelatine, melatonergic antidepressant and Valdoxan. FINDINGS: Agomelatine has antidepressa …
SCOPE: This is a review of current evidence for clinical efficacy and safety, drawn from a literature review using Medline and PsycInfo in 2 …
Agomelatine for depression: expanding the horizons?
Norman TR, Olver JS. Norman TR, et al. Expert Opin Pharmacother. 2019 Apr;20(6):647-656. doi: 10.1080/14656566.2019.1574747. Epub 2019 Feb 13. Expert Opin Pharmacother. 2019. PMID: 30759026 Review.
Agomelatine is an antidepressant with unique pharmacological actions; it is both a melatonin agonist and selective serotonin antagonist. ...Bipolar depression and seasonal affective disorder may also react favourably. ...
Agomelatine is an antidepressant with unique pharmacological actions; it is both a melatonin agonist and selective serotonin antagoni
Agomelatine: An Astounding Sui-generis Antidepressant?
Naveed M, Li LD, Sheng G, Du ZW, Zhou YP, Nan S, Zhu MY, Zhang J, Zhou QG. Naveed M, et al. Curr Mol Pharmacol. 2022;15(7):943-961. doi: 10.2174/1874467214666211209142546. Curr Mol Pharmacol. 2022. PMID: 34886787
In order to provide a critical analysis about antidepressant properties of agomelatine, a detailed PubMed (Medline), Scopus (Embase), Web of Science (Web of Knowledge), Cochrane Library, Google Scholar, and PsycInfo search was performed using the following keywords: melato …
In order to provide a critical analysis about antidepressant properties of agomelatine, a detailed PubMed (Medline), Scopus (Embase), …
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.
De Berardis D, Fornaro M, Serroni N, Campanella D, Rapini G, Olivieri L, Srinivasan V, Iasevoli F, Tomasetti C, De Bartolomeis A, Valchera A, Perna G, Mazza M, Di Nicola M, Martinotti G, Di Giannantonio M. De Berardis D, et al. Int J Mol Sci. 2015 Jan 5;16(1):1111-30. doi: 10.3390/ijms16011111. Int J Mol Sci. 2015. PMID: 25569089 Free PMC article. Review.
Agomelatine's antidepressant actions are attributed to its sleep-promoting and chronobiotic actions mediated by MT1 and MT2 receptors present in the suprachiasmatic nucleus, as well as to its effects on the blockade of 5-HT2c receptors. ...Agomelatine appeare
Agomelatine's antidepressant actions are attributed to its sleep-promoting and chronobiotic actions mediated by MT1 and MT2 re
Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data.
Calabrese JR, Guelfi JD, Perdrizet-Chevallier C; Agomelatine Bipolar Study Group. Calabrese JR, et al. Bipolar Disord. 2007 Sep;9(6):628-35. doi: 10.1111/j.1399-5618.2007.00507.x. Bipolar Disord. 2007. PMID: 17845278 Clinical Trial.
The aim of this study was to gather preliminary data regarding the antidepressant efficacy of agomelatine in patients with bipolar I disorder experiencing a major depressive episode. METHODS: Bipolar I patients on lithium (n = 14) or valpromide (n = 7), with …
The aim of this study was to gather preliminary data regarding the antidepressant efficacy of agomelatine in patients with bipolar
Agomelatine in depressive disorders: its novel mechanisms of action.
Srinivasan V, Zakaria R, Othman Z, Lauterbach EC, Acuña-Castroviejo D. Srinivasan V, et al. J Neuropsychiatry Clin Neurosci. 2012 Summer;24(3):290-308. doi: 10.1176/appi.neuropsych.11090216. J Neuropsychiatry Clin Neurosci. 2012. PMID: 23037643 Review.
Agomelatine has been shown to be effective in a number of animal models of depression. ...Agomelatine's action on dendritic neurogenesis in animal models of depression is also identified as yet another action....
Agomelatine has been shown to be effective in a number of animal models of depression. ...Agomelatine's action on dendr
Fibromyalgia and bipolar disorder: extent of comorbidity and therapeutic implications.
Di Tommaso Morrison MC, Carinci F, Lessiani G, Spinas E, Kritas SK, Ronconi G, Caraffa Al, Conti P. Di Tommaso Morrison MC, et al. J Biol Regul Homeost Agents. 2017 Jan-Mar;31(1):17-20. J Biol Regul Homeost Agents. 2017. PMID: 28337866 Review.
There exists strong evidence of a comorbidity between FM and Bipolar Disorder (BD). In this study, papers from 2006 to February 2016 that examined the comorbidity and etiological similarities of FM and BD were reviewed, as well as the therapeutic implications of these find …
There exists strong evidence of a comorbidity between FM and Bipolar Disorder (BD). In this study, papers from 2006 to February 2016 …
The use of agomelatine in OCD: effects on the motivational aspects and dysregulated circadian rhythms.
Perugi G, Quaranta G, Bucci N. Perugi G, et al. Expert Opin Investig Drugs. 2015 May;24(5):705-13. doi: 10.1517/13543784.2015.1021918. Epub 2015 Mar 1. Expert Opin Investig Drugs. 2015. PMID: 25727766 Review.
In particular, patients often continue to show disrupted circadian rhythms with related sleep disturbances and comorbidity with bipolar spectrum disorders. AREAS COVERED: This paper discusses the possible role of agomelatine in the treatment of motivational aspects …
In particular, patients often continue to show disrupted circadian rhythms with related sleep disturbances and comorbidity with bipolar
47 results